Effects of enteral immunonutrition enriched with multiple immunonutrients on clinical outcomes of patients who underwent gastric cancer surgery: a systematic review and meta-analysis
Abstract
Objective: To evaluate the clinical efficacy of enteral immunonutrition (EIN) compared to standard enteral nutrition (EN) in patients undergoing gastric cancer surgery.
Methods: We searched major databases for randomized controlled trials (RCTs) published up to December 2025. Nineteen RCTs involving 1,653 patients were included. Outcomes assessed included infectious and total complications, length of hospital stay (LOS), gastrointestinal tolerance, and immune-inflammatory markers.
Results: Compared to EN, EIN significantly reduced the incidence of infectious complications (OR = 0.48), gastrointestinal intolerance, and total complications. It also shortened LOS (MD = -1.24 days) and time to first flatus. EIN improved immune parameters (increased IgG, IgM, IgA, transferrin) and reduced inflammatory markers (WBC, CRP). Subgroup analysis indicated that perioperative administration yielded the most significant benefits, while preoperative-only intervention lacked sufficient evidence. Intervention durations > 7 days showed superior outcomes, with regimens within 10 days offering an optimal balance of efficacy and feasibility.
Conclusion: Perioperative enteral immunonutrition, particularly when administered for 7-10 days, is associated with reduced postoperative complications, improved humoral immunity, and shorter hospital stay in patients undergoing gastric cancer surgery. Given the moderate certainty of evidence for primary outcomes, the low certainty for several secondary…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,653 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.